Eagle Rock Health: Unlawful Drug Consent Failures - ID
Eagle Rock Health and Rehabilitation of Cascadia administered Aripiprazole to Resident #12 starting November 27, 2025, under a physician's order for the 5-milligram daily dose. The resident never signed consent forms acknowledging the medication's purpose, benefits, or risks before treatment began.
The consent violation continued for 50 days.
On April 1, 2026, at 9:48 AM, the facility's CEO presented inspectors with a signed consent document dated January 16, 2026. The form listed three psychiatric medications: Aripiprazole 5mg, Bupropion 150mg, and Fluoxetine 40mg.
One minute later, at 9:49 AM, the CEO admitted the facility had failed to follow proper procedures.
"Resident #12 should have signed a Psychotropic Medication Acknowledgement Consent prior to administration of Aripiprazole but had not," the CEO told inspectors.
Aripiprazole is an antipsychotic medication used to treat conditions including schizophrenia, bipolar disorder, and depression. Federal regulations require nursing homes to obtain informed consent before starting psychotropic drugs, ensuring residents understand why they're receiving the medication and what risks they face.
Resident #12 had been admitted to Eagle Rock Health with multiple serious conditions. The resident suffered from chronic obstructive pulmonary disease, which decreases lung function, along with depression and cardiomegaly, an enlarged heart condition.
The facility had readmitted the resident after an earlier stay, suggesting ongoing health complications requiring careful medication management.
The consent document eventually signed in January listed three psychiatric medications, indicating the resident was receiving multiple drugs affecting brain chemistry. Bupropion is an antidepressant, while Fluoxetine is another antidepressant commonly known as Prozac.
Federal inspectors determined the consent failure placed residents at risk of receiving medications without understanding their purpose or potential side effects. The violation affected informed decision-making about psychiatric treatment.
The inspection revealed the facility's systematic failure to follow medication consent procedures. While reviewing unnecessary medication practices, inspectors examined three residents and found one clear violation of informed consent requirements.
Eagle Rock Health's admission occurred only after inspectors requested documentation. The facility had nearly two months to obtain proper consent but failed to do so until federal oversight arrived.
The CEO's acknowledgment came with no explanation for the delay. The facility provided no documentation showing staff had attempted to obtain consent during the 50-day period between the medication order and the eventual signing.
Psychotropic medications carry significant risks for elderly residents, including increased fall risk, cognitive impairment, and potential interactions with other medications. Federal regulations specifically require facilities to ensure residents understand these risks before treatment begins.
The violation occurred despite clear regulatory requirements. Nursing homes must obtain written informed consent before administering psychotropic medications, explaining the medication's purpose, expected benefits, potential side effects, and alternatives.
Resident #12's complex medical conditions made proper consent even more critical. The combination of lung disease, heart problems, and depression required careful coordination of multiple medications and treatments.
The facility's failure extended beyond paperwork. By not obtaining consent, Eagle Rock Health denied the resident the opportunity to participate in treatment decisions and understand the medications being administered daily.
The January consent form came 50 days too late. During that period, Resident #12 received daily doses of Aripiprazole without the knowledge and understanding federal law requires.
Federal inspectors classified the violation as causing minimal harm but noted the potential for actual harm to residents receiving psychiatric medications without proper consent. The deficiency affected the facility's compliance with informed consent requirements designed to protect vulnerable residents.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Eagle Rock Health and Rehabilitation of Cascadia from 2026-04-02 including all violations, facility responses, and corrective action plans.
Additional Resources
- View all inspection reports for Eagle Rock Health and Rehabilitation of Cascadia
- Browse all ID nursing home inspections
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: June 15, 2026 · Our methodology
Eagle Rock Health and Rehabilitation of Cascadia in Idaho Falls, ID was cited for violations during a health inspection on April 2, 2026.
The resident never signed consent forms acknowledging the medication's purpose, benefits, or risks before treatment began.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.
Frequently Asked Questions
- What happened at Eagle Rock Health and Rehabilitation of Cascadia?
- The resident never signed consent forms acknowledging the medication's purpose, benefits, or risks before treatment began.
- How serious are these violations?
- Violation severity varies from minor documentation issues to serious safety concerns. Review the inspection report for specific deficiency codes and scope. All violations must be corrected within required timeframes and are subject to follow-up verification inspections.
- What should families do?
- Families should: (1) Ask facility administration about specific corrective actions taken, (2) Request to see the follow-up inspection report verifying corrections, (3) Check if this represents a pattern by reviewing prior inspection reports, (4) Compare this facility's ratings with other nursing homes in Idaho Falls, ID, (5) Report any new concerns directly to state authorities.
- Where can I see the full inspection report?
- The complete inspection report is available on Medicare.gov's Care Compare website (www.medicare.gov/care-compare). You can also request a copy directly from Eagle Rock Health and Rehabilitation of Cascadia or from the state Department of Health. The report includes specific deficiency codes, facility responses, and correction timelines. This facility's federal provider number is 135092.
- Has this facility had violations before?
- To check Eagle Rock Health and Rehabilitation of Cascadia's history, visit Medicare.gov's Care Compare and review their inspection history, quality ratings, and staffing levels. Look for patterns of repeated violations, especially in critical areas like abuse prevention, medication management, infection control, and resident safety.